# Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism

> **NCT01824121** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 25 (estimated)

## Conditions studied

- Progressive Supranuclear Palsy

## Interventions

- **BIOLOGICAL:** stem cell therapy

## Key facts

- **NCT ID:** NCT01824121
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824121, "Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01824121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*